logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11759441 B1

PDFFull Text
Date of Patent:
Sep. 19, 2023

Filed:

Jul. 14, 2021

Biguanide compositions and methods of treating metabolic disorders

Applicant:

Anji Pharmaceuticals Inc., Cambridge, MA (US);

Inventors:

Alain D. Baron, San Diego, CA (US);

Mark S. Fineman, San Diego, CA (US);

Nigel R. A. Beeley, Solana Beach, CA (US);

Assignee:

Anji Pharmaceuticals Inc., Cambridge, MA (US);

Attorneys:

Foley Hoag LLP

David P. Halstead

Primary Examiner:

H Sarah Park

Int. Cl.
CPC ...
A61K 31/155 (2006.01); A61P 3/10 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 9/28 (2006.01); A61K 45/06 (2006.01); A61K 31/341 (2006.01); A61K 31/36 (2006.01); A61K 31/381 (2006.01); A61K 31/40 (2006.01); A61K 31/53 (2006.01); A61K 31/4196 (2006.01); A61K 31/4453 (2006.01); A61K 31/454 (2006.01); A61K 31/55 (2006.01); A61P 3/08 (2006.01); A61K 31/137 (2006.01); A61K 31/35 (2006.01); A61K 31/485 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 9/2086 (2013.01); A61K 9/2806 (2013.01); A61K 9/4808 (2013.01); A61K 31/137 (2013.01); A61K 31/341 (2013.01); A61K 31/35 (2013.01); A61K 31/36 (2013.01); A61K 31/381 (2013.01); A61K 31/40 (2013.01); A61K 31/4196 (2013.01); A61K 31/4453 (2013.01); A61K 31/454 (2013.01); A61K 31/485 (2013.01); A61K 31/53 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01); A61P 3/08 (2018.01); A61P 3/10 (2018.01);
Abstract

Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.

Find Patent Forward Citations

Baron, Alain. (2023). Biguanide compositions and methods of treating metabolic disorders (U.S. Patent No. 11759441). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11759441

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…